Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2018 2
2019 1
2020 4
2021 6
2022 8
2023 14
2024 19
2025 24
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study.
Gargiulo L, Ferrucci SM, Ibba L, Ingurgio RC, Alfano A, Amoruso GF, Balato A, Barbagallo T, Barei F, Bellinato F, Brianti P, Burroni AG, Campanati A, Caroppo F, Carugno A, Bello GD, De Franco F, Fortina AB, Foti C, Gaiani FM, Girolomoni G, Gola M, Guanti MB, Gurioli C, Legori A, Loconsole F, Magnaterra E, Malagoli P, Margiotta FM, Marzano AV, Mercuri SR, Milanesi N, Musumeci ML, Napolitano M, Ortoncelli M, Paolino G, Patruno C, Pella P, Pezzolo E, Prestinari F, Recalcati S, Ribero S, Rongioletti F, Rossi M, Satolli F, Savoia P, Sciarrone C, Spigariolo C, Stabile G, Tirone B, Tolino E, Zerbinati N, Potenza C, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: rossi m. J Eur Acad Dermatol Venereol. 2025 Sep;39(9):e807-e811. doi: 10.1111/jdv.20699. Epub 2025 Apr 17. J Eur Acad Dermatol Venereol. 2025. PMID: 40247595 No abstract available.
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study.
Barei F, Macchi S, Calzari P, Ribero S, Ortoncelli M, Foti C, Balato A, Di Brizzi EV, Peris K, Gori N, Ippoliti E, Gurioli C, Piraccini BM, Trave I, Cozzani E, Pezzolo E, Bonzano L, Errichetti E, Schettini N, Nettis E, Gola M, Milanesi N, Feliciani C, De Felici Del Giudice MB, Campanati A, Gioacchini H, Pisapia A, Avallone G, Micali G, Musumeci ML, Ortega R, Manzo Margiotta F, Romanelli M, Hansel K, Stingeni L, Patruno C, Esposito M, Fargnoli MC, De Berardinis A, Ferreli C, Calabrese L, Rubegni P, Lazzeri L, Grigolato L, Galli B, Rossi M, Maurelli M, Girolomoni G, Lauletta G, Napolitano M, Alfano A, Gargiulo L, Narcisi A, Marzano AV, Ferrucci SM. Barei F, et al. Among authors: rossi m. Clin Exp Dermatol. 2025 Oct 27;50(11):2221-2231. doi: 10.1093/ced/llaf275. Clin Exp Dermatol. 2025. PMID: 40578600
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis.
Avallone G, Bombelli A, Valtellini L, Tavoletti G, Galli B, Rossi M, Maurelli M, Girolomoni G, Gargiulo L, Narcisi A, di Vico F, Napolitano M, Lazzeri L, Calabrese L, Caccavale S, Balato A, Barei F, Calzari P, Foti C, Trave I, Cozzani E, Rongioletti F, Lenti S, Gurioli C, Nettis E, Caroppo F, Errichetti E, Bonzano L, Gori N, Peris K, Lembo S, Del Regno L, Esposito M, Fargnoli MC, Savoia P, Esposto E, Giuffrida R, Guarneri F, Patruno C, Pezzolo E, Stingeni L, Hansel K, Mastorino L, Ortoncelli M, Ribero S, Marzano AV, Ferrucci SM. Avallone G, et al. Among authors: rossi m. Clin Exp Dermatol. 2025 Oct 27;50(11):2211-2220. doi: 10.1093/ced/llaf302. Clin Exp Dermatol. 2025. PMID: 40664380
Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes.
Barei F, Calzari P, Pezzolo E, Napolitano M, Rossi M, Guanti MB, Caroppo F, Belloni Fortina A, Patruno C, Campanati A, Bianchelli T, D'Agostino GM, Nettis E, Pugliese F, di Vico F, Trave I, Cozzani E, Stingeni L, Hansel K, Dall'Olio M, Grigolato L, Coppola R, Panasiti V, Maurelli M, Girolomoni G, Ortoncelli M, Ribero S, Marzano AV, Ferrucci SM. Barei F, et al. Among authors: rossi m. J Clin Med. 2025 Mar 18;14(6):2077. doi: 10.3390/jcm14062077. J Clin Med. 2025. PMID: 40142885 Free PMC article.
Letter: Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD.
Lauletta G, Potestio L, Patruno C, Ferrucci SM, Angileri L, Barei F, Ortoncelli M, Ribero S, Girolomoni G, Malagoli P, Pezzolo E, Narcisi A, Gargiulo L, Guanti MB, Musumeci ML, Ortega R, Gurioli C, Campanati A, Caroppo F, Legori A, Rossi M, Tolino E, D'Erme AM, Milanesi N, Sciarrone C, Gola M, Magnaterra E, Grieco T, Satolli F, Loconsole F, Brianti P, Stingeni L, Hansel K, Bertoldi AM, Napolitano M. Lauletta G, et al. Among authors: rossi m. Dermatitis. 2026 Jan;37(1):134-139. doi: 10.1089/derm.2025.0129. Epub 2026 Feb 6. Dermatitis. 2026. PMID: 40470535 No abstract available.
Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce.
Musters AH, Gerbens LAA, van der Gang L, Middelkamp-Hup MA, Ouwerkerk W, Hijnen DJ, Haufe E, Heinrich L, Werfel T, Weidinger S, Schmitt J, Svedbom A, Johansson EK, Bradley M, von Kobyletzki LB, Vittrup I, Ruge IF, Thyssen JP, Vestergaard C, Carrascosa JM, de Vega M, García-Doval I, Chiricozzi A, Stingeni L, Calzavara-Pinton P, Ardern-Jones MR, Reynolds NJ, Flohr C, Spuls PI; A‐STAR, AtopyReg, BIOBADATOP, SCRATCH, SwedAD, TREATgermany and TREAT NL/BE registry teams. Musters AH, et al. J Eur Acad Dermatol Venereol. 2025 Dec;39(12):2096-2112. doi: 10.1111/jdv.20876. Epub 2025 Aug 20. J Eur Acad Dermatol Venereol. 2025. PMID: 40832875 Free PMC article.
Letter: Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence.
Barei F, Calzari P, Macchi S, Ribero S, Ortoncelli M, Foti C, Balato A, Di Brizzi EV, Peris K, Gori N, De Luca E, Gurioli C, Piraccini BM, Pezzolo E, Bonzano L, Errichetti E, Schettini N, Nettis E, Gola M, Milanesi N, Feliciani C, De Felici Del Giudice MB, Caroppo F, Belloni Fortina A, Campanati A, Gioacchini H, Manzo Margiotta F, Romanelli M, Hansel K, Stingeni L, Calabrese L, Rubegni P, Lazzeri L, Grigolato L, Galli B, Rossi M, Maurelli M, Girolomoni G, Coronella L, Patruno C, Napolitano M, Alfano A, Gargiulo L, Narcisi A, Marzano AV, Ferrucci SM. Barei F, et al. Among authors: rossi m. Dermatitis. 2026 Jan;37(1):143-148. doi: 10.1177/17103568251381792. Epub 2026 Feb 6. Dermatitis. 2026. PMID: 41203246 No abstract available.
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.
Avallone G, Bombelli A, Gargiulo L, Foti C, Trave I, Rossi M, Magnaterra E, Pigliacelli F, Malagoli P, Giacalone S, Portarapillo A, Patruno C, Schettini N, Bonzano L, Pezzolo E, Chello C, Gori N, Brunasso G, Veronese F, Ortoncelli M, Tolino E, Azzolini A, Bellinato F, Hansel K, Di Brizzi EV, Gurioli C, Esposito M, Giuffrida R, Barei F, Calzari P, Burroni AG, Gola M, Mariano M, Fargnoli MC, Napolitano M, Grieco T, Peris K, Savoia P, Ribero S, Girolomoni G, Stingeni L, Balato A, Costanzo A, Marzano AV, Narcisi A, Ferrucci SM. Avallone G, et al. Among authors: rossi m. Dermatol Ther (Heidelb). 2025 Dec;15(12):3671-3688. doi: 10.1007/s13555-025-01550-8. Epub 2025 Oct 10. Dermatol Ther (Heidelb). 2025. PMID: 41071522 Free PMC article.
83 results